Category

Expert Review of Pharmacoeconomic

Home > Papers-Magazines > Expert Review of Pharmacoeconomic

De la Cuadra-Grande A, Rioja-Zuazu J, Domínguez-Esteban M, Torres E, Blissett R, Woodward E, Oyagüez I, Fernández-Arjona M

 

 

Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system
Expert Rev Pharmacoecon Outcomes Res. 2023; vol. 23, no. 5, 499–510

Taxonera C, de Andrés-Nogales F, García-López S, Sánchez-Guerrero A, Menchén B, Peral C, Cábez A, Gómez S, López-Ibáñez de Aldecoa A, Casado MA, Menchén L

 

Cost-Effectiveness Analysis of Using Innovative Therapies for the Management of Moderate-To-Severe Ulcerative Colitis in Spain
Expert Rev Pharmacoecon Outcomes Res. 2021. Doi: .1080/14737167.2021.1880324

Gros B, Soto J, Casado MA

 

 

 

Incorporation of future costs in health economic analysis publications: Current situation and recommendations for the future
Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):465-9

Barbieri M, Drummond M, Puig-Junoy J, Casado MA, Ballina FJ, Blasco P, Poveda JL

 

 

A critical appraisal of pharmacoeconomic studies comparing TNFa antagonists for the treatment of rheumatoid arthritis
Exp Rev Pharmacoeconomic Outcomes Res. 2007;7:613-26